Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data
Year: 2019
Type: article
Study design: Observational Study
Abstract: Alzheimer's disease (AD) is the most common subtype of dementia, followed by Vascular Dementia (VaD), and Dementia with Lewy Bodies (DLB). Recently, microRNAs (miRNAs) have received a lot of attention as the novel biomarkers for dementia. Here, using serum miRNA expression of 1,601 Japanese individuals, we investigated potential miRNA biomarkers and constructed risk prediction models, based on a supervised principal component analysis (PCA) logistic regression method, according to the subtype of dementia. The final risk prediction model achieved a high accuracy of 0.873 on a validation cohort in AD, when using 78 miRNAs: Accuracy = 0.836 with 86 miRNAs in VaD; Accuracy = 0.825 with 110 miRNAs in DLB. To our knowledge, this is the first report applying miRNA-based risk prediction models to a dementia prospective cohort. Our study demonstrates our models to be effective in prospective disease risk prediction, and with further improvement may contribute to practical clinical use in dementia.
Source: Communications Biology
Authors: Daichi Shigemizu, Shintaro Akiyama, Yuya Asanomi, Keith A. Boroevich, Alok Sharma, Tatsuhiko Tsunoda, Kana Matsukuma, Makiko Ichikawa, Hiroko Sudo, Satoko Takizawa, Takashi Sakurai, Kouichi Ozaki, Takahiro Ochiya, Shumpei Niida
Institutions: Tokyo Medical and Dental University, Japan Science and Technology Agency, RIKEN Center for Integrative Medical Sciences, National Center for Geriatrics and Gerontology, Medical Genome Center, National Center for Geriatrics and Gerontology, Griffith University, University of the South Pacific, Toray Industries, Inc. (Japan), Center for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Nagoya University, Tokyo Medical University, National Cancer Center Research Institute
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,170
Awards: The innovative drug development that targeted molecules associated with coronary artery diseases and its functional analysis, G6908052415, Comprehensive research on statistical methodologies and their applications for development of personalized medicine, Establishment of a novel strategy for pathological analysis of multifactorial diseases using genetic risk variants
OpenAlex ID: W2915790112
